Publications by authors named "Joseph Lasky"

Claim this Profile
A
Associations of interstitial lung disease subtype and CT pattern with lung function and survival.
John S Kim, Janelle Pugashetti, Shwu-Fan Ma, Yong Huang, Anna J Podolanczuk, Joseph A Lasky

Thorax· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoliposome for Ewing Sarcoma.
Daniel E Panosyan, William S Panosyan, Daron S Yacoubian, Joseph L Lasky

Cancer Genomics Proteomics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactivation of CTLA4-expressing T cells accelerates resolution of lung fibrosis in a humanized mouse model.
Santosh Yadav, Muralidharan Anbalagan, Shamima Khatun, Devadharshini Prabhakaran, Yasuka Matsunaga, Joseph A Lasky

J Clin Invest· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic Signature-Guided Depletion of Intermediate Alveolar Epithelial Cells Ameliorates Pulmonary Fibrosis in Mice.
Yong Zhou, Fei Peng, Chun-Sun Jiang, Zhen Zheng, Shahram Aliyari, Joseph Lasky

Res Sq· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: Data from the IPF-PRO Registry.
Olawale Amubieya, Jamie L Todd, Megan L Neely, Robert J Kaner, Joseph A Lasky

PLoS One· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry.
Christopher S King, Rosalinda V Ignacio, Vikramjit Khangoora, Alan Nyquist, Anju Singhal, Joseph Lasky

Am J Respir Crit Care Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gammaherpesvirus Infection Stimulates Lung Tumor-Promoting Inflammation.
Sudurika S Mukhopadhyay, Kenneth F Swan, Gabriella Pridjian, Jay K Kolls, Yan Zhuang, Joseph A Lasky

Pathogens· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.
Ganesh Raghu, Marya Ghazipura, Thomas R Fleming, Kerri I Aronson, Jürgen Behr, Joseph A Lasky

Am J Respir Crit Care Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.
Sydney B Montesi, Christian R Gomez, Michael Beers, Robert Brown, Ishanu Chattopadhyay, Joseph Lasky

Am J Respir Crit Care Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients.
Naveen Pemmaraju, Branko Cuglievan, Joseph Lasky, Albert Kheradpour, Nobuko Hijiya

EJHaem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Blinatumomab as upfront consolidation and maintenance therapy in a pediatric patient with high-risk B-cell acute lymphoblastic leukemia.
Sumit Gupta, Jessica Casey, Joseph Lasky

Front Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.
Margaret V Ragni, Scott D Rothenberger, Robert Feldman, Danielle Nance, Andrew D Leavitt, Joseph Lasky

Lancet Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Expression of a Novel Lamin A/C Splice Variant in Idiopathic Pulmonary Fibrosis Lung.
Qinyan Yin, Gilbert F Morris, Shigeki Saito, Yan Zhuang, Victor J Thannickal, Joseph A Lasky

Am J Respir Cell Mol Biol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interstitial lung disease progression after genomic usual interstitial pneumonia testing.
Sachin Chaudhary, S Sam Weigt, Manuel L Ribeiro Neto, Bryan S Benn, Janelle Vu Pugashetti, Joseph A Lasky

Eur Respir J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH-ing up Surface Tension in the Fibrotic Lung.
Joseph A Lasky, Victor J Thannickal

Am J Respir Crit Care Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Joshua J Solomon, Sonye K Danoff, Felix A Woodhead, Shelley Hurwitz, Rie Maurer, Joseph A Lasky

Lancet Respir Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial.
Anna J Podolanczuk, John S Kim, Christopher B Cooper, Joseph A Lasky, Susan Murray

BMC Pulm Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic and Lung Platelet Biogenesis as a Prognostic Indicator in Idiopathic Pulmonary Fibrosis.
Shigeki Saito, Cheng Han H Chung, Alex Jacob, Nebil Nuradin, Amy E Meyer, Joseph A Lasky

Am J Respir Crit Care Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel mediators of idiopathic pulmonary fibrosis.
Shigeki Saito, Brian Deskin, Mohammad Rehan, Santosh Yadav, Yasuka Matsunaga, Joseph A Lasky

Clin Sci (Lond)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis.
Joseph A Lasky, Amy Case, Avraham Unterman, Michael Kreuter, Mary Beth Scholand

Ann Am Thorac Soc· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Patients With Sickle Cell Disease at a Public Hospital: Nutrition, Compliance and Early Experience With L-Glutamine Therapy.
Moran Gotesman, Guy Elgar, Laura Hernandez Santiago, Abigail Alvarez, Youngju Pak, Joseph L Lasky

In Vivo· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy Can Synergize With Adoptive Immunotherapy to Inhibit Medulloblastoma Growth.
Joseph L Lasky, Kathryn L Bradford, Yuntao Wang, Youngju Pak, Eduard H Panosyan

Anticancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort.
Jamie L Todd, Megan L Neely, Robert Overton, Hillary Mulder, Jesse Roman, Joseph A Lasky

Lung· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort.
Jamie L Todd, Megan L Neely, Robert Overton, Hillary Mulder, Jesse Roman, Joseph A Lasky

Lung· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
James F Casella, Bruce A Barton, Julie Kanter, L Vandy Black, Suvankar Majumdar, Joseph L Lasky

JAMA· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis